Filing Details
- Accession Number:
- 0000950103-20-012253
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-06-23 21:14:27
- Reporting Period:
- 2020-06-15
- Accepted Time:
- 2020-06-23 21:14:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1802768 | Royalty Pharma Plc | RPRX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1016835 | B Rory Riggs | C/O Royalty Pharma Plc 110 E. 59Th Street New York NY 10022 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Ordinary Shares | Acquisiton | 2020-06-18 | 15,000 | $28.00 | 15,000 | No | 4 | P | Indirect | By Spouse |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By Spouse |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class A Ordinary Shares | LP interests in RPI US Partners 2019, LP | Acquisiton | 2020-06-15 | 238,001 | $0.00 | 2,380,010 | $0.00 |
| Class A Ordinary Shares | LP interests in RPI US Partners 2019, LP | Acquisiton | 2020-06-15 | 435,267 | $0.00 | 4,352,670 | $0.00 |
| Class A Ordinary Shares | LP interests in RPI US Partners 2019, LP | Acquisiton | 2020-06-15 | 253,889 | $0.00 | 2,538,890 | $0.00 |
| Class A Ordinary Shares | LP interests in RPI International Holdings 2019, LP | Acquisiton | 2020-06-15 | 494,485 | $0.00 | 4,944,850 | $0.00 |
| Class A Ordinary Shares | LP interests in RPI International Holdings 2019, LP | Acquisiton | 2020-06-15 | 119,982 | $0.00 | 1,199,820 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 238,001 | No | 4 | A | Direct | ||
| 435,267 | No | 4 | A | Direct | ||
| 253,889 | No | 4 | A | Indirect | ||
| 494,485 | No | 4 | A | Indirect | ||
| 119,982 | No | 4 | A | Indirect |
Footnotes
- The Reporting Person acquired beneficial ownership of Class B Interests in Royalty Pharma Holdings, Ltd. ("Holdings") and became entitled to indirect rights to exchange such Class B Interests for Class A Ordinary Shares of the Issuer in connection with a reorganization prior to closing of the Issuer's initial public offering (as more fully described in the Issuer's Registration Statement on Form S-1 (File No. 333-238632)). The reorganization involved the exchange of interests in Royalty Pharma Investments 2019 ICAV held by RPI US Partners 2019, LP ("RPI US LP") and RPI International Holdings 2019, LP ("RPI Intl. LP") for interests in Holdings. The reorganization and the acquisition of these exchange rights occurred on June 15, 2020.
- Represents limited partnership interests in RPI US Partners 2019, LP ("RPI US LP Interests"). Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged upon such exchange for one Class A Ordinary Share of the Issuer for no additional value.
- Includes RPI US LP Interests convertible into 172,210 Class A Ordinary Shares that are subject to forfeiture if and when the Class A Ordinary Shares attain a 20-trading day volume weighted average price of $32.30 or more after December 15, 2020 and on or before December 15, 2023. The amount of this forfeiture scales linearly from 0% at $20.51 per share to 100% at $32.30 per share.
- Includes RPI US LP Interests convertible into 183,700 Class A Ordinary Shares that are subject to forfeiture if and when the Class A Ordinary Shares attain a 20-trading day volume weighted average price of $32.30 or more after December 15, 2020 and on or before December 15, 2023. The amount of this forfeiture scales linearly from 0% at $20.51 per share to 100% at $32.30 per share.
- Represents limited partnership interests in RPI Intl. LP Interests. Each RPI Intl. LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Each Class B Interest in Holdings issued in exchange for a RPI Intl. LP Interest will be exchanged upon such exchange for one Class A Ordinary Share of the Issuer for no additional value.
- Includes RPI Intl. LP Interests convertible into 357,780 Class A Ordinary Shares that are subject to forfeiture if and when the Class A Ordinary Shares attain a 20-trading day volume weighted average price of $32.30 or more after December 15, 2020 and on or before December 15, 2023. The amount of this forfeiture scales linearly from 0% at $20.51 per share to 100% at $32.30 per share.
- Includes RPI Intl. LP Interests convertible into 86,810 Class A Ordinary Shares that are subject to forfeiture if and when the Class A Ordinary Shares attain a 20-trading day volume weighted average price of $32.30 or more after December 15, 2020 and on or before December 15, 2023. The amount of this forfeiture scales linearly from 0% at $20.51 per share to 100% at $32.30 per share.
Billionaire Hedge Funds
